| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.28 | 6e-16 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-14 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-12 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-09 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |